Nanocyte Inc.
Records under this name other than patents Nanocyte Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,337,868 | Stinging Cells Expressing an Exogenous Polynucleotide Encoding a Therapeutic, Diagnostic or a Cosmetic Agent and Methods Compositions and Devices Utilizing Such Stinging Cells or Capsules Derived Therefrom for Delivering the Therapeutic, Diagnostic or Cosmetic Agen Term ended Ended no later than Apr 19, 2024 · Medium confidence | Term ended | Ended no later than Apr 19, 2024 | Medium confidence |
| US 8,834,862 | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Formerly held Lapsed on the fee record Ended Sep 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2022 | From the USPTO record |
| US 6,923,976 | Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering Therapeutic or a Cosmetic Agent into a Tissue Term ended Term ended Jul 7, 2022 · High confidence | Term ended | Term ended Jul 7, 2022 | High confidence |
| US 7,611,723 | Stinging Cells Expressing an Exogenous Polynucleotide Encoding a Therapeutic, Diagnostic or a Cosmetic Agent and Methods Compositions and Devices Utilizing Such Stinging Cells or Capsules Derived Therefrom for Delivering the Therapeutic, Diagnostic or Cosmetic Agen Lapsed on the fee record Ended Nov 3, 2021 · High confidence | Lapsed on the fee record | Ended Nov 3, 2021 | High confidence |
| US 6,613,344 | Methods Utilizing Stinging Cells/Capsules Term ended Term ended Sep 27, 2021 · High confidence | Term ended | Term ended Sep 27, 2021 | High confidence |
| US 7,632,522 | Use of stinging cells/capsules for the delivery of active agents to keratinous substances Term ended Ended no later than Sep 27, 2021 · From the USPTO record | Term ended | Ended no later than Sep 27, 2021 | From the USPTO record |
| US 8,486,441 | Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue Lapsed on the fee record Ended Jul 16, 2021 · Medium confidence | Lapsed on the fee record | Ended Jul 16, 2021 | Medium confidence |
| US 8,287,912 | Use of stinging cells/capsules for the delivery of active agents to keratinous substances Lapsed on the fee record Ended Oct 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2020 | From the USPTO record |
| US 7,338,665 | Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue Lapsed on the fee record Ended Mar 4, 2020 · High confidence | Lapsed on the fee record | Ended Mar 4, 2020 | High confidence |
| US 8,062,660 | Methods Compositions and Devices Utilizing Stinging Cells/Capsules for Delivering a Therapeutic or a Cosmetic Agent into a Tissue Lapsed on the fee record Ended Nov 22, 2019 · High confidence | Lapsed on the fee record | Ended Nov 22, 2019 | High confidence |